Elizabeth Juarez-Colunga
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 6 | 2024 | 138 | 1.310 |
Why?
| | Models, Statistical | 5 | 2026 | 677 | 0.880 |
Why?
| | Vigabatrin | 2 | 2022 | 19 | 0.820 |
Why?
| | Arthroplasty, Replacement, Knee | 5 | 2025 | 383 | 0.690 |
Why?
| | Isoantibodies | 1 | 2021 | 57 | 0.660 |
Why?
| | Pseudomonas Infections | 2 | 2022 | 231 | 0.640 |
Why?
| | Graft Rejection | 2 | 2021 | 523 | 0.630 |
Why?
| | Cystic Fibrosis | 5 | 2025 | 1171 | 0.600 |
Why?
| | Machine Learning | 2 | 2021 | 596 | 0.570 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 69 | 0.550 |
Why?
| | Algorithms | 3 | 2025 | 1868 | 0.540 |
Why?
| | Vaccination Coverage | 1 | 2019 | 106 | 0.520 |
Why?
| | Behavior Therapy | 2 | 2019 | 297 | 0.490 |
Why?
| | Health Education | 1 | 2019 | 346 | 0.460 |
Why?
| | Longitudinal Studies | 6 | 2026 | 3027 | 0.450 |
Why?
| | Papillomavirus Vaccines | 1 | 2019 | 296 | 0.440 |
Why?
| | Risk Assessment | 5 | 2019 | 3784 | 0.430 |
Why?
| | Internet | 2 | 2020 | 696 | 0.430 |
Why?
| | Walking | 6 | 2026 | 549 | 0.430 |
Why?
| | Humans | 82 | 2026 | 147293 | 0.420 |
Why?
| | Papillomavirus Infections | 1 | 2019 | 345 | 0.420 |
Why?
| | Advance Care Planning | 4 | 2025 | 244 | 0.410 |
Why?
| | Data Mining | 1 | 2014 | 114 | 0.370 |
Why?
| | Epilepsies, Myoclonic | 3 | 2018 | 62 | 0.370 |
Why?
| | Amputees | 2 | 2026 | 101 | 0.370 |
Why?
| | Female | 57 | 2026 | 80076 | 0.360 |
Why?
| | Treatment Outcome | 9 | 2026 | 11947 | 0.360 |
Why?
| | Renal Dialysis | 2 | 2026 | 467 | 0.340 |
Why?
| | Osteoarthritis, Knee | 3 | 2025 | 284 | 0.340 |
Why?
| | Veterans | 7 | 2025 | 1675 | 0.330 |
Why?
| | Male | 50 | 2026 | 73950 | 0.330 |
Why?
| | Primary Health Care | 5 | 2026 | 1759 | 0.330 |
Why?
| | Epileptic Syndromes | 3 | 2021 | 98 | 0.320 |
Why?
| | Exercise Therapy | 3 | 2025 | 489 | 0.310 |
Why?
| | Family Planning Services | 2 | 2022 | 93 | 0.310 |
Why?
| | Down Syndrome | 3 | 2021 | 526 | 0.300 |
Why?
| | Postoperative Complications | 6 | 2018 | 3022 | 0.300 |
Why?
| | Aged | 28 | 2026 | 26514 | 0.300 |
Why?
| | Kidney Failure, Chronic | 2 | 2026 | 600 | 0.300 |
Why?
| | Recovery of Function | 5 | 2026 | 724 | 0.300 |
Why?
| | Tacrolimus | 2 | 2021 | 196 | 0.290 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1940 | 0.280 |
Why?
| | Contraception | 2 | 2022 | 170 | 0.280 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2973 | 0.280 |
Why?
| | Vision Disorders | 2 | 2021 | 179 | 0.280 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1072 | 0.270 |
Why?
| | Exercise | 3 | 2025 | 2219 | 0.270 |
Why?
| | Biomarkers | 4 | 2021 | 4351 | 0.270 |
Why?
| | Community Health Workers | 2 | 2026 | 93 | 0.260 |
Why?
| | Research Design | 1 | 2013 | 1157 | 0.250 |
Why?
| | Child | 18 | 2025 | 22979 | 0.250 |
Why?
| | Anticonvulsants | 2 | 2022 | 253 | 0.250 |
Why?
| | Middle Aged | 26 | 2026 | 36821 | 0.240 |
Why?
| | Patient Navigation | 2 | 2026 | 130 | 0.240 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 29 | 0.240 |
Why?
| | Arthroplasty, Replacement, Shoulder | 1 | 2026 | 41 | 0.230 |
Why?
| | Self-Management | 2 | 2025 | 204 | 0.230 |
Why?
| | Developmental Disabilities | 2 | 2019 | 284 | 0.220 |
Why?
| | Patient Portals | 1 | 2025 | 52 | 0.220 |
Why?
| | Retrospective Studies | 18 | 2026 | 17560 | 0.220 |
Why?
| | Electroencephalography | 3 | 2024 | 570 | 0.220 |
Why?
| | Monte Carlo Method | 3 | 2026 | 148 | 0.210 |
Why?
| | Advance Directives | 1 | 2025 | 89 | 0.210 |
Why?
| | Markov Chains | 3 | 2026 | 132 | 0.210 |
Why?
| | Adult | 24 | 2026 | 41405 | 0.210 |
Why?
| | Patient Reported Outcome Measures | 2 | 2026 | 506 | 0.210 |
Why?
| | Quality Improvement | 6 | 2019 | 1321 | 0.200 |
Why?
| | Hospitalization | 4 | 2020 | 2496 | 0.200 |
Why?
| | Adipose Tissue, Brown | 1 | 2024 | 60 | 0.200 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 21 | 0.200 |
Why?
| | Preoperative Care | 2 | 2016 | 381 | 0.200 |
Why?
| | Renal Insufficiency | 1 | 2025 | 172 | 0.200 |
Why?
| | Ambulatory Care Facilities | 1 | 2026 | 269 | 0.200 |
Why?
| | Task Performance and Analysis | 1 | 2024 | 203 | 0.190 |
Why?
| | Lower Extremity | 2 | 2024 | 452 | 0.190 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 165 | 0.190 |
Why?
| | Surgical Procedures, Operative | 2 | 2016 | 272 | 0.190 |
Why?
| | Postural Balance | 1 | 2026 | 254 | 0.190 |
Why?
| | United States | 17 | 2026 | 16313 | 0.180 |
Why?
| | Group Processes | 2 | 2020 | 63 | 0.180 |
Why?
| | Aged, 80 and over | 11 | 2026 | 8430 | 0.180 |
Why?
| | Logistic Models | 4 | 2021 | 2142 | 0.180 |
Why?
| | Artificial Limbs | 1 | 2026 | 215 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1344 | 0.180 |
Why?
| | Spasm | 1 | 2022 | 21 | 0.180 |
Why?
| | Cosyntropin | 1 | 2022 | 7 | 0.180 |
Why?
| | Patient Readmission | 2 | 2018 | 777 | 0.170 |
Why?
| | Weight Gain | 1 | 2026 | 566 | 0.170 |
Why?
| | Adolescent | 16 | 2024 | 22825 | 0.170 |
Why?
| | Accidental Falls | 1 | 2024 | 231 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2016 | 1043 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 464 | 0.170 |
Why?
| | Kidney Pelvis | 1 | 2021 | 22 | 0.170 |
Why?
| | Computer Simulation | 2 | 2026 | 1018 | 0.170 |
Why?
| | Activities of Daily Living | 1 | 2024 | 449 | 0.170 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 479 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2026 | 389 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 506 | 0.160 |
Why?
| | Palliative Care | 2 | 2026 | 1032 | 0.160 |
Why?
| | Ureteral Obstruction | 1 | 2021 | 64 | 0.160 |
Why?
| | Telemedicine | 3 | 2025 | 978 | 0.160 |
Why?
| | Disease Progression | 4 | 2022 | 2890 | 0.160 |
Why?
| | Text Messaging | 1 | 2022 | 189 | 0.150 |
Why?
| | Seizures | 1 | 2024 | 491 | 0.150 |
Why?
| | ROC Curve | 1 | 2021 | 626 | 0.150 |
Why?
| | Mobile Applications | 1 | 2022 | 199 | 0.150 |
Why?
| | Resuscitation Orders | 1 | 2020 | 48 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 227 | 0.150 |
Why?
| | Emergency Service, Hospital | 2 | 2026 | 2416 | 0.150 |
Why?
| | Inpatients | 3 | 2021 | 556 | 0.150 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 840 | 0.140 |
Why?
| | Postnatal Care | 1 | 2019 | 76 | 0.140 |
Why?
| | Sleep | 2 | 2024 | 895 | 0.140 |
Why?
| | Epilepsy | 2 | 2024 | 399 | 0.140 |
Why?
| | Prostatic Neoplasms | 1 | 2026 | 986 | 0.140 |
Why?
| | Medical History Taking | 1 | 2019 | 119 | 0.140 |
Why?
| | Age Factors | 6 | 2025 | 3372 | 0.140 |
Why?
| | Graft Survival | 1 | 2021 | 534 | 0.140 |
Why?
| | Gait | 1 | 2021 | 317 | 0.140 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 6011 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2023 | 569 | 0.140 |
Why?
| | Rural Health Services | 1 | 2019 | 139 | 0.140 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.130 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 236 | 0.130 |
Why?
| | Antibody Formation | 1 | 2019 | 288 | 0.130 |
Why?
| | Hospital Costs | 1 | 2019 | 130 | 0.130 |
Why?
| | Automobile Driver Examination | 1 | 2017 | 9 | 0.130 |
Why?
| | Child, Preschool | 10 | 2025 | 12016 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 173 | 0.130 |
Why?
| | Young Adult | 9 | 2024 | 14437 | 0.130 |
Why?
| | Community Health Services | 1 | 2019 | 231 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 164 | 0.130 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 141 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2021 | 441 | 0.130 |
Why?
| | Symptom Assessment | 1 | 2019 | 137 | 0.130 |
Why?
| | Postoperative Care | 2 | 2017 | 299 | 0.130 |
Why?
| | Thoracoscopy | 1 | 2017 | 60 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1220 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2679 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1121 | 0.130 |
Why?
| | Mass Screening | 1 | 2026 | 1375 | 0.130 |
Why?
| | Thyrotropin | 1 | 2017 | 120 | 0.130 |
Why?
| | Croup | 1 | 2017 | 19 | 0.130 |
Why?
| | Automobile Driving | 2 | 2016 | 159 | 0.120 |
Why?
| | Hydrocarbons | 1 | 2016 | 29 | 0.120 |
Why?
| | Caregivers | 1 | 2026 | 1091 | 0.120 |
Why?
| | Esophagectomy | 1 | 2018 | 136 | 0.120 |
Why?
| | Mental Disorders | 2 | 2016 | 1188 | 0.120 |
Why?
| | Lung | 3 | 2023 | 4141 | 0.120 |
Why?
| | Time Factors | 5 | 2026 | 7173 | 0.120 |
Why?
| | Construction Industry | 1 | 2016 | 22 | 0.120 |
Why?
| | Patient Participation | 1 | 2020 | 449 | 0.120 |
Why?
| | Air Pollutants, Occupational | 1 | 2016 | 41 | 0.120 |
Why?
| | Infant | 9 | 2024 | 10194 | 0.120 |
Why?
| | Colorado | 5 | 2026 | 4591 | 0.120 |
Why?
| | Transgender Persons | 1 | 2020 | 214 | 0.120 |
Why?
| | Cross Infection | 1 | 2019 | 261 | 0.120 |
Why?
| | Quality of Life | 2 | 2026 | 3246 | 0.120 |
Why?
| | Patient Discharge | 3 | 2025 | 1002 | 0.120 |
Why?
| | Polysomnography | 1 | 2017 | 240 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1776 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 951 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 147 | 0.120 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 210 | 0.120 |
Why?
| | Body Composition | 1 | 2020 | 694 | 0.120 |
Why?
| | Hormone Replacement Therapy | 1 | 2017 | 109 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 167 | 0.120 |
Why?
| | Tissue Donors | 1 | 2019 | 427 | 0.110 |
Why?
| | Medicaid | 2 | 2020 | 475 | 0.110 |
Why?
| | Health Resources | 1 | 2017 | 132 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 397 | 0.110 |
Why?
| | Heart Arrest | 1 | 2020 | 412 | 0.110 |
Why?
| | Organ Transplantation | 1 | 2019 | 258 | 0.110 |
Why?
| | Treatment Failure | 1 | 2016 | 360 | 0.110 |
Why?
| | Obesity | 2 | 2019 | 3149 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 318 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2020 | 480 | 0.110 |
Why?
| | Rehabilitation Centers | 1 | 2015 | 39 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 795 | 0.110 |
Why?
| | Data Collection | 1 | 2017 | 652 | 0.110 |
Why?
| | Risk Factors | 6 | 2019 | 11017 | 0.100 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 107 | 0.100 |
Why?
| | Life Change Events | 1 | 2015 | 149 | 0.100 |
Why?
| | Nutrition Surveys | 1 | 2016 | 279 | 0.100 |
Why?
| | Perception | 1 | 2017 | 378 | 0.100 |
Why?
| | Independent Living | 1 | 2015 | 116 | 0.100 |
Why?
| | Physician-Patient Relations | 2 | 2016 | 594 | 0.100 |
Why?
| | Accelerometry | 2 | 2025 | 126 | 0.100 |
Why?
| | Vaccines | 1 | 2019 | 389 | 0.100 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 545 | 0.100 |
Why?
| | Poisson Distribution | 1 | 2013 | 78 | 0.100 |
Why?
| | Patient Admission | 1 | 2016 | 220 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 440 | 0.100 |
Why?
| | Hospitals | 2 | 2016 | 740 | 0.100 |
Why?
| | Esophageal Neoplasms | 1 | 2018 | 351 | 0.100 |
Why?
| | Testosterone | 1 | 2017 | 417 | 0.100 |
Why?
| | General Surgery | 1 | 2016 | 207 | 0.100 |
Why?
| | Physician's Role | 1 | 2015 | 225 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2014 | 196 | 0.100 |
Why?
| | Cognition | 2 | 2025 | 1286 | 0.090 |
Why?
| | Insurance, Health | 1 | 2016 | 321 | 0.090 |
Why?
| | Nursing Homes | 1 | 2015 | 174 | 0.090 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 303 | 0.090 |
Why?
| | Occupational Exposure | 1 | 2016 | 357 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2019 | 732 | 0.090 |
Why?
| | Walk Test | 2 | 2023 | 82 | 0.090 |
Why?
| | Parents | 2 | 2021 | 1428 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2014 | 502 | 0.090 |
Why?
| | Prospective Studies | 2 | 2022 | 8164 | 0.090 |
Why?
| | Databases, Factual | 4 | 2018 | 1504 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2020 | 1253 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2016 | 583 | 0.080 |
Why?
| | Cohort Studies | 5 | 2021 | 6099 | 0.080 |
Why?
| | Body Mass Index | 1 | 2020 | 2470 | 0.080 |
Why?
| | Histones | 1 | 2016 | 672 | 0.080 |
Why?
| | Single-Blind Method | 2 | 2021 | 319 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2016 | 625 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2014 | 786 | 0.080 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 6164 | 0.080 |
Why?
| | Recurrence | 1 | 2013 | 1151 | 0.080 |
Why?
| | Length of Stay | 4 | 2018 | 1371 | 0.080 |
Why?
| | Vaccination | 1 | 2019 | 1443 | 0.080 |
Why?
| | Child Abuse | 1 | 2015 | 558 | 0.070 |
Why?
| | Pregnancy Complications | 1 | 2015 | 606 | 0.070 |
Why?
| | Influenza Vaccines | 1 | 2014 | 541 | 0.070 |
Why?
| | Preventive Health Services | 2 | 2020 | 154 | 0.070 |
Why?
| | Postoperative Period | 2 | 2021 | 351 | 0.070 |
Why?
| | Guatemala | 2 | 2019 | 347 | 0.070 |
Why?
| | Sex Factors | 3 | 2020 | 2136 | 0.070 |
Why?
| | Brain Concussion | 1 | 2016 | 661 | 0.070 |
Why?
| | Comorbidity | 3 | 2017 | 1672 | 0.070 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2017 | 24 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2218 | 0.060 |
Why?
| | Morbidity | 2 | 2019 | 323 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2026 | 35 | 0.060 |
Why?
| | Mothers | 2 | 2022 | 774 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2334 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2014 | 2017 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 1147 | 0.050 |
Why?
| | Survival Rate | 2 | 2020 | 2110 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2026 | 312 | 0.050 |
Why?
| | Prognosis | 2 | 2026 | 4383 | 0.050 |
Why?
| | Equivalence Trials as Topic | 1 | 2024 | 35 | 0.050 |
Why?
| | Pilot Projects | 2 | 2020 | 1912 | 0.050 |
Why?
| | Habits | 1 | 2024 | 52 | 0.050 |
Why?
| | Femur | 1 | 2026 | 261 | 0.050 |
Why?
| | Thermogenesis | 1 | 2024 | 45 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2026 | 428 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 417 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2026 | 363 | 0.050 |
Why?
| | Epilepsies, Partial | 1 | 2024 | 63 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 222 | 0.050 |
Why?
| | Wakefulness | 1 | 2024 | 171 | 0.050 |
Why?
| | Survival Analysis | 1 | 2026 | 1386 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 207 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 217 | 0.050 |
Why?
| | Pseudomonas | 1 | 2022 | 30 | 0.040 |
Why?
| | Language | 1 | 2025 | 326 | 0.040 |
Why?
| | Vulnerable Populations | 1 | 2023 | 177 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 344 | 0.040 |
Why?
| | Cotinine | 1 | 2021 | 77 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 368 | 0.040 |
Why?
| | Hydronephrosis | 1 | 2021 | 36 | 0.040 |
Why?
| | Socioeconomic Factors | 2 | 2016 | 1342 | 0.040 |
Why?
| | Pregnancy | 3 | 2019 | 7274 | 0.040 |
Why?
| | Smoking Prevention | 1 | 2021 | 167 | 0.040 |
Why?
| | Quadriceps Muscle | 1 | 2021 | 120 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 138 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 134 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2020 | 1214 | 0.040 |
Why?
| | Milk, Human | 1 | 2022 | 176 | 0.040 |
Why?
| | Home Health Nursing | 1 | 2019 | 13 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Urologic Surgical Procedures | 1 | 2021 | 121 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2020 | 142 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 379 | 0.040 |
Why?
| | Muscle Strength | 1 | 2021 | 336 | 0.030 |
Why?
| | Health Behavior | 1 | 2024 | 799 | 0.030 |
Why?
| | Reproductive Health | 1 | 2019 | 94 | 0.030 |
Why?
| | Glucose | 1 | 2024 | 1051 | 0.030 |
Why?
| | Breast Feeding | 1 | 2022 | 447 | 0.030 |
Why?
| | Documentation | 1 | 2020 | 204 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5476 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2021 | 873 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 132 | 0.030 |
Why?
| | Peer Group | 1 | 2020 | 258 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 528 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 936 | 0.030 |
Why?
| | House Calls | 1 | 2019 | 154 | 0.030 |
Why?
| | Snoring | 1 | 2017 | 19 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1735 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 374 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 181 | 0.030 |
Why?
| | Perioperative Period | 1 | 2017 | 71 | 0.030 |
Why?
| | Mentoring | 1 | 2020 | 166 | 0.030 |
Why?
| | Women's Health | 1 | 2019 | 317 | 0.030 |
Why?
| | Pandemics | 1 | 2025 | 1720 | 0.030 |
Why?
| | Cesarean Section | 1 | 2019 | 230 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 150 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2016 | 25 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 189 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 185 | 0.030 |
Why?
| | Oximetry | 1 | 2017 | 125 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 205 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 339 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 4130 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 502 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 563 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 653 | 0.030 |
Why?
| | Housing for the Elderly | 1 | 2015 | 7 | 0.030 |
Why?
| | Financing, Personal | 1 | 2015 | 27 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 646 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 296 | 0.030 |
Why?
| | Health Surveys | 1 | 2017 | 522 | 0.030 |
Why?
| | Probability | 1 | 2016 | 309 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 227 | 0.030 |
Why?
| | Risk | 1 | 2017 | 927 | 0.030 |
Why?
| | Lymphocytes | 1 | 2016 | 378 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 915 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 151 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2016 | 451 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1483 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2016 | 240 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 2017 | 288 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2016 | 347 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2016 | 369 | 0.030 |
Why?
| | Rural Population | 1 | 2019 | 684 | 0.020 |
Why?
| | Health Services Research | 1 | 2016 | 392 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 895 | 0.020 |
Why?
| | Depression | 1 | 2023 | 1599 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2016 | 337 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2015 | 538 | 0.020 |
Why?
| | Weight Loss | 1 | 2019 | 867 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2133 | 0.020 |
Why?
| | Body Weight | 1 | 2017 | 976 | 0.020 |
Why?
| | Life Style | 1 | 2016 | 504 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 2017 | 0.020 |
Why?
| | Disease Management | 1 | 2017 | 654 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3660 | 0.020 |
Why?
| | Oxygen | 1 | 2017 | 998 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 571 | 0.020 |
Why?
| | Surgeons | 1 | 2016 | 342 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2016 | 551 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1145 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2017 | 928 | 0.020 |
Why?
| | Registries | 1 | 2020 | 2434 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3448 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6543 | 0.020 |
Why?
|
|
Juarez-Colunga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|